Related references
Note: Only part of the references are listed.Pharmacometrics in Pregnancy: An Unmet Need
Alice Ban Ke et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19
Alice Ban Ke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Pharmacokinetics of Indomethacin in Pregnancy
Erik Rytting et al.
CLINICAL PHARMACOKINETICS (2014)
A Simplified PBPK Modeling Approach for Prediction of Pharmacokinetics of Four Primarily Renally Excreted and CYP3A Metabolized Compounds During Pregnancy
Binfeng Xia et al.
AAPS JOURNAL (2013)
A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
Alice Ban Ke et al.
DRUG METABOLISM AND DISPOSITION (2013)
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
Lu Gaohua et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy
Khaled Abduljalil et al.
CLINICAL PHARMACOKINETICS (2012)
Prevention of Preterm Labour: 2011 Update on Tocolysis
C. Hubinont et al.
JOURNAL OF PREGNANCY (2011)
Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes
Hyunyoung Jeong
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
Stefan S. De Buck et al.
DRUG METABOLISM AND DISPOSITION (2007)
Oral lipid-based formulations
David J. Hauss
ADVANCED DRUG DELIVERY REVIEWS (2007)
Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
Yuji Mano et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Kinetic disposition of lorazepam with focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples
O Papini et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Glucuronidation of nonsteroidal anti-inflammatory drugs: Identifying the enzymes responsible in human liver microsomes
GE Kuehl et al.
DRUG METABOLISM AND DISPOSITION (2005)
Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen
G Giagoudakis et al.
PHARMACOTHERAPY (2005)
Pharmacokinetics of tocolytic agents
V Tsatsaris et al.
CLINICAL PHARMACOKINETICS (2004)
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs
F Faasen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor
RJ Sawdy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Pharmacokinetic study of the hepatobiliary transport of indomethacin
H Kouzuki et al.
PHARMACEUTICAL RESEARCH (2000)